⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1630402 | 0.81 | ALDH1A1 (0.35) | — | |
| SCHEMBL10520708 | 0.73 | ALDH1A1 (0.37) | — | |
| SCHEMBL28456688 | 0.63 | — | — | |
| SCHEMBL1352445 | 0.63 | GABRR1 (0.32) | — | |
| SCHEMBL2986477 | 0.63 | ALDH1A1 (0.32) | — | |
| Hydrochloric Acid SCHEMBL2417834 | 0.61 | ALDH1A1 (0.30) | — | |
| SCHEMBL9510919 | 0.60 | ALDH1A1 (0.35) | — | |
| SCHEMBL2271926 | 0.58 | — | — | |
| SCHEMBL28437964 | 0.58 | — | — | |
| SCHEMBL293271 | 0.58 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-107074755-A | Herbicides compounds | 先正达参股股份有限公司 | 2017-08-18 | — | — | CN | disclosed |
| EP-0948483-B1 | FARNESYL TRANSFERASE INHIBITORS | AVENTIS PHARMA SA (FR) | 2002-03-13 | — | — | EP | disclosed |
| EP-1075541-A1 | ELECTRONIC DETECTION OF NUCLEIC ACIDS USING MONOLAYERS | Clinical Micro Sensors (US) | 2001-02-14 | — | — | EP | disclosed |
| EP-1042329-A1 | NOVEL FARNESYL TRANSFERASE INHIBITORS, PREPARATION, PHARMACEUTICAL, COMPOSITIONS CONTAINING THEM AND USE FOR PREPARING MEDICINES | Aventis Pharma S.A. (FR) | 2000-10-11 | — | — | EP | disclosed |
| WO-1999057319-A1 | ELECTRONIC DETECTION OF NUCLEIC ACIDS USING MONOLAYERS | CLINICAL MICRO SENSORS (US) | 1999-11-11 | — | — | WO | disclosed |
| EP-0948483-A1 | FARNESYL TRANSFERASE INHIBITORS | Aventis Pharma S.A. (FR) | 1999-10-13 | — | — | EP | disclosed |
| EP-0839133-B1 | 4,9-ETHANO-BENZO(F)ISOINDOLE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS | RHONE POULENC RORER SA (FR) | 1999-10-06 | — | — | EP | disclosed |
| WO-1999033834-A1 | NOVEL FARNESYL TRANSFERASE INHIBITORS, PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND USE FOR PREPARING MEDICINES | AVENTIS PHARMA S.A. (FR) | 1999-07-08 | — | — | WO | disclosed |
| EP-0759934-B1 | NEUROTENSIN ANTAGONIST PEPTIDES | RHONE POULENC RORER SA (FR) | 1999-04-14 | — | — | EP | disclosed |
| WO-1998029390-A1 | FARNESYL TRANSFERASE INHIBITORS | RHONE-POULENC RORER S.A. (FR) | 1998-07-09 | — | — | WO | disclosed |
| EP-0839133-A1 | 4,9-ETHANO-BENZO(F)ISOINDOLE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS | Aventis Pharma S.A. (FR) | 1998-05-06 | — | — | EP | disclosed |
| WO-1997003050-A1 | 4,9-ETHANO-BENZO(F)ISOINDOLE DERIVATIVES AS FARNESYL TRANSFERASE INHIBITORS | RHONE-POULENC RORER S.A. (FR) | 1997-01-30 | — | — | WO | disclosed |